Review | SARS-COV-2 Neutralizing Antibodies

Team Annar
Content creation
SHARE

Review SARS-COV-2 Neutralizing Antibodies

Casa Comercial Asociada: DIA.PRO


Neutralizing antibodies to SARS COV 2 are antibodies capable of stopping the binding of host cell receptors to the virus receptor located on the spicule.

They are relevant because they are the antigenic target for vaccine development, and are responsible for host protection against infection.

Currently there are in vitro diagnostic products that allow the quantification of these IgG isotype antibodies that, when used with responsibility and knowledge, will provide valuable information to improve the management of vaccines and the knowledge of this viral infection.

 

 


 

Most viewed

3D bioprinted organs for experimental transplantation: current status, challenges and perspectives

Exploramos cómo el trasplante parcial de corazón transforma la cardiología pediátrica al ofrecer soluciones más humanas y adaptadas al crecimiento del paciente

When the heart grows with the patient: a new frontier in pediatric cardiology

Six Sigma and its application in the clinical laboratory

The Human Perspective on Cancer